Faisal Zain stands at the forefront of the intersection between healthcare delivery and medical technology, bringing years of specialized experience in medical device manufacturing and diagnostic innovation. As an expert who has seen the evolution of clinical tools from simple hardware to complex, AI-driven ecosystems, he offers a unique vantage point on how technology reshapes the administrative and clinical landscape. Today, we explore the intricate dynamics of clinical documentation, the reality behind shifting patient acuity, and the ongoing friction between providers and insurers regarding the use of artificial intelligence in coding.
AI tools like digital scribes are increasingly used to streamline clinical documentation. How do these tools specifically reshape the daily experience for clinicians, and what impact do they have on the quality of patient care?
The implementation of AI scribes is more than just a convenience; it is a fundamental shift in how doctors interact with the people in their care. For years, the healthcare system has been bogged down by a staggering $1 trillion in annual administrative spending, much of which stems from clinicians spending more time with their keyboards than their patients. By deploying these AI tools, we are seeing a dramatic reduction in documentation time, which directly translates into expanded appointment capacity and a noticeable lift in staff morale. When a physician isn’t frantically typing to keep up with a patient’s medical history, they can maintain eye contact and pick up on the subtle, non-verbal cues that are so vital to a correct diagnosis. This precision doesn’t just stop at the bedside; it carries through to the patient’s chart, ensuring that the documentation is a rigorous and accurate reflection of the clinical encounter.
There have been claims that the use of AI in coding has artificially inflated “coding intensity.” Based on the data regarding patient demographics and chronic disease, how do you respond to the suggestion that these tools are being used for “upcoding”?
The narrative that AI is being used to “upcode” simply doesn’t hold water when you look at the raw data regarding the people actually occupying hospital beds today. We are dealing with an aging population and a significant rise in chronic conditions like heart disease, cancer, and liver disease, which naturally increases the complexity of care. Between 2019 and 2024, we saw hospital case-mix indexes—the standard measure of patient sickness—rise by approximately 5%, proving that the patients we treat now have far greater clinical needs than in the past. In fact, 19% of hospital expense growth during that same five-year period was a direct result of caring for these sicker, more complex patients who require intensive monitoring and specialized treatment. To suggest that more detailed coding is a result of “AI manipulation” ignores the reality that hospitals are legally and ethically obligated to document the high-acuity care they are actually providing to a sicker America.
How has the continued movement of lower-acuity procedures to outpatient settings changed the “new normal” for inpatient hospital environments?
The shift of routine, less complex care to outpatient settings has fundamentally altered the DNA of the modern hospital. What remains within the hospital walls is a concentrated population of high-acuity patients who require around-the-clock specialized staffing and resource-intensive services. This “new normal” means that the average inpatient is significantly more ill than they were a decade ago, requiring longer stays and more sophisticated medical interventions. Because the simpler cases have moved to clinics and ambulatory centers, the hospital’s remaining caseload is naturally skewed toward higher-level diagnostic codes. This isn’t a strategy to increase reimbursement; it is a structural evolution of the healthcare system where the hospital has become a specialized hub for the most critical and complex medical challenges.
Recent reports highlight a significant tension between hospitals and commercial insurers regarding reimbursement. Can you elaborate on the practice of “downcoding” and how it affects the financial stability of healthcare providers?
We are seeing a troubling trend where some commercial insurers use automated edits to unilaterally reduce reimbursement for medically necessary care that has already been delivered, a practice often called “downcoding.” It is a glaring double standard: insurers argue that their enrollee populations are sicker to justify higher risk scores for their own payments, yet they claim those same patients are “healthier” when it comes time to pay the hospital’s claims. The administrative waste this creates is immense, as providers are forced into costly and burdensome appeals processes just to be paid for the work they have already performed. This isn’t just a theoretical debate; in 2025 alone, MedPAC reported that insurer-led upcoding contributed to $40 billion in overpayments to Medicare Advantage plans. We’ve even seen major legal action recently, such as the March 2026 settlement between a large payer and the Department of Justice, and the May 2026 lawsuit in Massachusetts, both of which highlight how insurers are the ones often engaging in the very practices they accuse providers of using.
What is your forecast for the role of AI in the relationship between hospitals and insurers over the next few years?
My forecast is that AI will become the primary “referee” in the ongoing tug-of-war between clinical reality and financial reimbursement, though the transition will be rocky. We are moving toward a future where AI-driven auditing and compliance programs within hospitals will become so robust that they will provide an indisputable, real-time trail of patient acuity that insurers will find increasingly difficult to deny. However, the friction will likely intensify in the short term as insurers continue to deploy “black box” algorithms for partial denials, forcing a standoff that may eventually require federal intervention to standardize how AI-generated documentation is validated. Ultimately, the goal is to reach a point where technology serves as a bridge of trust, ensuring that $1 trillion in administrative waste is redirected back into the life-saving treatments and diagnostic innovations that patients truly deserve.
